Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamza Sayadi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Plos One|April 28, 2025
Optimizing CMV therapy: Population pharmacokinetics and Monte Carlo simulations for letermovir and maribavir dosageYeleen Fromage, Hamza Sayadi, Sophie Alain, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2025
Reducing aztreonam/avibactam waste: insights from Monte Carlo simulationsYeleen Fromage, Hamza Sayadi, Marc Labriffe, et al.
Therapeutic Drug Monitoring|September 12, 2024
Daptomycin Dosage Optimization in Renal Impairment Using Model-Informed Precision DosingHamza Sayadi, Yeleen Fromage, Marc Labriffe, et al.
British Journal of Clinical Pharmacology|December 22, 2024
Killing several birds with one stone: A multi-indication population pharmacokinetic model and Bayesian estimator for enteric-coated mycophenolate sodiumYeleen Fromage, Hamza Sayadi, Kevin Koloskoff, et al.
European Journal of Clinical Pharmacology|June 1, 2024
Synergizing pharmacometrics and pharmacovigilance for medication error management: the case of secukinumabYeleen Fromage, Hamza Sayadi, Caroline Monchaud, et al.
Plos One|August 28, 2025
Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategiesFranck Maizaud, Selim Arraki-Zava, Hamza Sayadi, et al.
Therapeutic Drug Monitoring|February 11, 2025
Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug MonitoringHamza Sayadi, Yeleen Fromage, Caroline Monchaud, et al.
Expert Review of Clinical Pharmacology|December 29, 2025
Optimized therapeutic drug monitoring: the role of machine learning modelsHamza Sayadi, Yeleen Fromage, Marc Labriffe, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2026
Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosingYeleen Fromage, Hamza Sayadi, Marc Labriffe, et al.
Therapeutic Drug Monitoring|August 28, 2025
Large-Scale Real-World Monitoring of Mycophenolic Acid Exposure in Liver Transplantation: Impact of Bayesian Dose AdjustmentMarc Labriffe, Hamza Sayadi, Jean-Baptiste Woillard, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|April 28, 2025
Optimizing CMV therapy: Population pharmacokinetics and Monte Carlo simulations for letermovir and maribavir dosageYeleen Fromage, Hamza Sayadi, Sophie Alain, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2025
Reducing aztreonam/avibactam waste: insights from Monte Carlo simulationsYeleen Fromage, Hamza Sayadi, Marc Labriffe, et al.
Therapeutic Drug Monitoring|September 12, 2024
Daptomycin Dosage Optimization in Renal Impairment Using Model-Informed Precision DosingHamza Sayadi, Yeleen Fromage, Marc Labriffe, et al.
British Journal of Clinical Pharmacology|December 22, 2024
Killing several birds with one stone: A multi-indication population pharmacokinetic model and Bayesian estimator for enteric-coated mycophenolate sodiumYeleen Fromage, Hamza Sayadi, Kevin Koloskoff, et al.
European Journal of Clinical Pharmacology|June 1, 2024
Synergizing pharmacometrics and pharmacovigilance for medication error management: the case of secukinumabYeleen Fromage, Hamza Sayadi, Caroline Monchaud, et al.
Plos One|August 28, 2025
Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategiesFranck Maizaud, Selim Arraki-Zava, Hamza Sayadi, et al.
Therapeutic Drug Monitoring|February 11, 2025
Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug MonitoringHamza Sayadi, Yeleen Fromage, Caroline Monchaud, et al.
Expert Review of Clinical Pharmacology|December 29, 2025
Optimized therapeutic drug monitoring: the role of machine learning modelsHamza Sayadi, Yeleen Fromage, Marc Labriffe, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2026
Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosingYeleen Fromage, Hamza Sayadi, Marc Labriffe, et al.
Therapeutic Drug Monitoring|August 28, 2025
Large-Scale Real-World Monitoring of Mycophenolic Acid Exposure in Liver Transplantation: Impact of Bayesian Dose AdjustmentMarc Labriffe, Hamza Sayadi, Jean-Baptiste Woillard, et al.
Pageof 2